Xeris Pharmaceuticals Inc. (XERS) Earnings
|
Expand Research on XERS
| Next EPS Date | 8/6/26 | EPS Growth Rate | +200.0% |
|---|---|---|---|
| Average EPS % Beat Rate | +41.7% | Revenue Growth Rate | +27.0% |
| Average % Move 1-Wk after EPS | +1.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/6/26  |
Q226 | N/A | $0.01 | N/A | N/A | $90.86M | = | N/A | N/A | ||
| 5/7/26 | Q126 | $0.01 | $0.00 | +$0.01 | $83.13M | $83.7M | = |  | | Details | |
| 3/2/26 | Q425 | $0.06 | $0.02 | +$0.04 | $85.81M | $81.38M | = | | | Details | |
| 11/6/25 | Q325 | $0.00 | $0.01 | -$0.01 | $74.38M | $74.2M | = | | | Details | |
| 8/7/25 | Q225 | -$0.01 | -$0.03 | +$0.02 | $71.54M | $63.96M | = | | | Details | |
| 5/8/25 | Q125 | -$0.06 | -$0.05 | -$0.01 | $60.12M | $57.88M | = | | | Details | |
| 3/6/25 | Q424 | -$0.03 | -$0.06 | +$0.03 | $60.1M | $55.99M | = | | | Details | |
| 11/8/24 | Q324 | -$0.11 | -$0.09 | -$0.02 | $54.3M | $51.45M | = | | | Details |
